Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
O75071
UPID:
EFC14_HUMAN
Alternative names:
-
Alternative UPACC:
O75071; D3DQ23; Q5SXB8
Background:
EF-hand calcium-binding domain-containing protein 14, identified by the accession number O75071, plays a crucial role in calcium signaling, a pivotal process for cellular function and communication. The EF-hand motif, a helix-loop-helix structural domain, is known for its ability to bind calcium ions, suggesting this protein's involvement in calcium-mediated cellular processes.
Therapeutic significance:
Understanding the role of EF-hand calcium-binding domain-containing protein 14 could open doors to potential therapeutic strategies. Its involvement in calcium signaling pathways offers a promising avenue for the development of interventions targeting diseases where calcium homeostasis is disrupted.